|
Percentage of methylated CpG in various normal and tumor cell lines. Sequence analysis was performed after bisulfite treatment. |
||
| Cells |
Tumor type |
meth CpG |
|
|
||
| CCL-75 |
Fibroblast |
5% |
| NHBE |
Normal |
6.3% |
| SAEC |
Normal |
4.5% |
| A460 |
Large cell |
7.9% |
| H838 |
Adenocarcinoma |
8.2% |
| H1703 |
Squamous cell |
6.6% |
| A549 |
Adenocarcinoma |
5.1% |
| MS1 |
Mesothelioma |
2.2% |
| H290 |
Mesothelioma |
4% |
| MCF-7 |
Breast cancer |
1.6% |
| BT474 |
Breast cancer |
2% |
Mazières et al. BMC Cancer 2007 7:220 doi:10.1186/1471-2407-7-220 |
||